ondansetron has been researched along with Cardiac Arrest, Sudden in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marzuillo, P | 1 |
| Benettoni, A | 1 |
| Germani, C | 1 |
| Ferrara, G | 1 |
| D'Agata, B | 1 |
| Barbi, E | 1 |
1 review available for ondansetron and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Acquired long QT syndrome: a focus for the general pediatrician.
Topics: Adolescent; Death, Sudden, Cardiac; Electrocardiography; Female; General Practitioners; Humans; Long | 2014 |